GLP-1 course compounds. Semaglutide, tirzepatide, and liraglutide are authorised medicinal items within the Netherlands and have elevated regulatory and import scrutiny. Any framing that provides them as therapeutic solutions to prescription medicines delivers them under the Geneesmiddelenwet and it